About Elsevier Research Intelligence
Elsevier Research Intelligence is a research information management portfolio that improves institutional and individual ability to establish, execute and evaluate research strategy and performance. Combining SciVal tools, the Pure system and custom Analytical Services with the rich data asset Scopus and the reference management technology of Mendeley, Elsevier Research Intelligence equips research institutions, funders, policy-makers and researchers with a wide range of content, tools, and powerful analytics. Elsevier Research Intelligence helps individuals and institutions make better decisions, improve collaboration, attract more investment and optimize expenditure.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). Media contact Iris Kisjes Senior Manager Corporate Relations +31-20-485-3072 I.Kisjes@elsevier.com SOURCE Elsevier
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts